Cumberland Depreciation vs Free Cash Flow Analysis

CPIX Stock  USD 1.06  0.02  1.85%   
Cumberland Pharmaceuticals financial indicator trend analysis is way more than just evaluating Cumberland Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cumberland Pharmaceuticals is a good investment. Please check the relationship between Cumberland Pharmaceuticals Depreciation and its Free Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cumberland Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.

Depreciation vs Free Cash Flow

Depreciation vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cumberland Pharmaceuticals Depreciation account and Free Cash Flow. At this time, the significance of the direction appears to have weak relationship.
The correlation between Cumberland Pharmaceuticals' Depreciation and Free Cash Flow is 0.35. Overlapping area represents the amount of variation of Depreciation that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Cumberland Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Cumberland Pharmaceuticals' Depreciation and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation of Cumberland Pharmaceuticals are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Depreciation i.e., Cumberland Pharmaceuticals' Depreciation and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

0.35
Relationship DirectionPositive 
Relationship StrengthVery Weak

Depreciation

Depreciation indicates how much of Cumberland Pharmaceuticals value has been used up. For tax purposes Cumberland Pharmaceuticals can deduct the cost of the tangible assets it purchases as business expenses. However, Cumberland Pharmaceuticals must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
Most indicators from Cumberland Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cumberland Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cumberland Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.Discontinued Operations is likely to rise to about 2.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 8.9 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense98.0K586.0K667.9K701.3K
Depreciation And Amortization4.6M5.3M5.8M6.1M

Cumberland Pharmaceuticals fundamental ratios Correlations

0.390.520.480.640.090.87-0.230.390.330.50.490.50.490.10.370.540.38-0.090.430.050.750.190.660.180.13
0.390.680.92-0.440.60.380.69-0.590.83-0.390.87-0.530.75-0.650.990.580.550.170.980.53-0.22-0.160.760.770.89
0.520.680.84-0.130.390.490.42-0.240.58-0.240.69-0.240.69-0.450.680.620.310.240.770.350.05-0.120.80.30.54
0.480.920.84-0.340.550.480.67-0.460.86-0.420.93-0.480.82-0.70.920.580.430.330.970.49-0.17-0.050.90.690.81
0.64-0.44-0.13-0.34-0.380.53-0.820.85-0.380.87-0.290.96-0.180.68-0.470.02-0.05-0.3-0.42-0.360.940.3-0.05-0.43-0.61
0.090.60.390.55-0.380.410.63-0.760.72-0.390.54-0.480.54-0.620.53-0.020.160.130.550.99-0.31-0.40.30.790.7
0.870.380.490.480.530.41-0.10.140.50.40.50.380.51-0.090.330.280.44-0.050.40.410.60.110.570.390.22
-0.230.690.420.67-0.820.63-0.1-0.850.74-0.910.64-0.930.4-0.930.690.260.110.560.70.6-0.74-0.360.480.710.88
0.39-0.59-0.24-0.460.85-0.760.14-0.85-0.630.73-0.390.87-0.350.76-0.58-0.03-0.21-0.18-0.54-0.750.740.43-0.13-0.69-0.8
0.330.830.580.86-0.380.720.50.74-0.63-0.460.8-0.530.73-0.840.80.420.440.340.840.7-0.230.00.710.810.86
0.5-0.39-0.24-0.420.87-0.390.4-0.910.73-0.46-0.420.95-0.150.81-0.42-0.060.13-0.65-0.43-0.370.880.35-0.27-0.47-0.63
0.490.870.690.93-0.290.540.50.64-0.390.8-0.42-0.470.75-0.680.870.420.420.370.920.47-0.21-0.110.910.80.77
0.5-0.53-0.24-0.480.96-0.480.38-0.930.87-0.530.95-0.47-0.270.82-0.55-0.06-0.04-0.44-0.53-0.460.920.34-0.25-0.59-0.73
0.490.750.690.82-0.180.540.510.4-0.350.73-0.150.75-0.27-0.460.740.330.40.040.790.46-0.020.10.680.570.55
0.1-0.65-0.45-0.70.68-0.62-0.09-0.930.76-0.840.81-0.680.82-0.46-0.65-0.21-0.25-0.58-0.68-0.610.620.09-0.57-0.73-0.82
0.370.990.680.92-0.470.530.330.69-0.580.8-0.420.87-0.550.74-0.650.610.540.180.980.46-0.25-0.180.760.730.89
0.540.580.620.580.02-0.020.280.26-0.030.42-0.060.42-0.060.33-0.210.610.270.090.61-0.050.28-0.070.640.090.51
0.380.550.310.43-0.050.160.440.11-0.210.440.130.42-0.040.4-0.250.540.27-0.230.50.130.10.110.390.370.38
-0.090.170.240.33-0.30.13-0.050.56-0.180.34-0.650.37-0.440.04-0.580.180.09-0.230.250.13-0.380.030.40.260.29
0.430.980.770.97-0.420.550.40.7-0.540.84-0.430.92-0.530.79-0.680.980.610.50.250.49-0.22-0.130.840.730.87
0.050.530.350.49-0.360.990.410.6-0.750.7-0.370.47-0.460.46-0.610.46-0.050.130.130.49-0.29-0.380.240.750.66
0.75-0.220.05-0.170.94-0.310.6-0.740.74-0.230.88-0.210.92-0.020.62-0.250.280.1-0.38-0.22-0.290.30.05-0.4-0.43
0.19-0.16-0.12-0.050.3-0.40.11-0.360.430.00.35-0.110.340.10.09-0.18-0.070.110.03-0.13-0.380.30.05-0.27-0.38
0.660.760.80.9-0.050.30.570.48-0.130.71-0.270.91-0.250.68-0.570.760.640.390.40.840.240.050.050.540.62
0.180.770.30.69-0.430.790.390.71-0.690.81-0.470.8-0.590.57-0.730.730.090.370.260.730.75-0.4-0.270.540.83
0.130.890.540.81-0.610.70.220.88-0.80.86-0.630.77-0.730.55-0.820.890.510.380.290.870.66-0.43-0.380.620.83
Click cells to compare fundamentals

Cumberland Pharmaceuticals Account Relationship Matchups

Cumberland Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets104.5M96.5M84.5M92.9M81.8M88.1M
Short Long Term Debt Total21.5M17.1M16.1M21.0M18.4M11.9M
Other Current Liab7.7M9.1M8.7M17.6M13.6M7.7M
Total Current Liabilities24.2M25.7M19.3M28.6M28.0M16.8M
Total Stockholder Equity51.1M47.0M42.8M36.3M29.6M58.3M
Property Plant And Equipment Net3.7M2.6M1.5M5.5M7.0M7.4M
Net Debt(6.7M)(7.7M)(11.0M)1.2M106.9K112.2K
Retained Earnings1.2M(2.1M)(5.6M)(11.2M)(17.5M)(16.6M)
Accounts Payable10.0M13.4M9.6M10.8M14.0M14.7M
Cash28.2M24.8M27.0M19.8M18.3M27.3M
Non Current Assets Total54.4M46.5M38.8M47.1M46.1M27.5M
Cash And Short Term Investments28.2M24.8M27.0M19.8M18.3M31.1M
Net Receivables7.9M12.4M6.9M13.2M9.8M7.4M
Common Stock Shares Outstanding15.4M15.2M14.9M14.6M14.3M13.5M
Liabilities And Stockholders Equity104.5M96.5M84.5M92.9M81.8M88.1M
Non Current Liabilities Total29.3M23.9M22.6M28.4M24.5M13.1M
Inventory8.9M10.6M8.4M9.4M4.6M7.3M
Other Current Assets2.8M2.2M6.7M3.1M3.0M2.4M
Other Stockholder Equity2.9M3.1M3.4M(212.3K)(244.2K)(256.4K)
Total Liab53.5M49.6M41.9M57.0M52.5M29.9M
Property Plant And Equipment Gross3.7M2.6M1.5M5.5M9.3M9.7M
Total Current Assets50.2M50.0M45.7M45.9M35.7M60.5M
Intangible Assets30.9M28.1M24.0M30.6M22.6M19.2M
Non Currrent Assets Other18.9M14.9M12.5M10.0M15.5M16.3M
Other Liab8.7M7.9M7.5M7.6M8.7M9.2M
Other Assets18.9M17.8M12.5M10.0M11.6M7.4M
Long Term Debt20M18.5M15M16.2M12.8M9.3M
Common Stock49.9M49.1M48.5M47.5M47.1M44.7M
Property Plant Equipment16.3M12.2M1.5M5.5M6.3M6.6M
Net Tangible Assets19.3M18.0M18.0M4.8M4.3M4.1M
Noncontrolling Interest In Consolidated Entity(198.6K)(274.3K)(37.6K)(117.1K)(105.4K)(110.7K)
Common Stock Total Equity52.4M51.1M49.9M49.1M44.2M46.2M
Retained Earnings Total Equity11.7M4.7M1.2M(2.1M)(1.9M)(1.8M)
Long Term Debt Total9.8M20M18.5M15M17.3M10.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.